Prostate Cancer - Results from #28460

A pilot study of endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging changes with dutasteride in patients with low risk prostate cancer - Abstract April 15, 2011

Constitutional risk factors in prostate cancer - Abstract April 15, 2011

Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: Tumor detection and assessment of aggressiveness - Abstract April 15, 2011

Penile implant utilization following treatment for prostate cancer: Analysis of the SEER-Medicare database - Abstract April 14, 2011

Estrogen-initiated transformation of prostate epithelium derived from normal human prostate stem-progenitor cells - Abstract April 14, 2011

Robotic radical prostatectomy: A critical analysis of the impact on cancer control - Abstract April 14, 2011

Biochemical recurrence after radical prostatectomy with or without pelvic lymphadenectomy in Korean men with high-risk prostate cancer - Abstract April 14, 2011

Antioxidant effects of lycopene in African American men with prostate cancer or benign prostate hyperplasia: A randomized controlled trial - Abstract April 14, 2011

Castration-resistant prostate cancer: Targeted therapies - Abstract April 14, 2011

Robotic high-intensity focused ultrasound for prostate cancer: What have we learned in 15 years of clinical use? - Abstract April 14, 2011

Risedronate prevents persistent bone loss in prostate cancer patients treated with androgen deprivation therapy: Results of a 2-year follow-up study - Abstract April 13, 2011

The patient after radical prostatectomy : Complexity and efficiency of a urological rehabilitation program - Abstract April 13, 2011

Durable remission of leptomeningeal metastases from hormone-responsive prostate cancer - Abstract April 13, 2011

Association of serum α-tocopherol with sex steroid hormones and interactions with smoking: Implications for prostate cancer risk - Abstract April 13, 2011

Current perspectives on Gleason grading of prostate cancer - Abstract April 13, 2011

Bone and metabolic health in patients with non-metastatic prostate cancer who are receiving androgen deprivation therapy - Abstract April 13, 2011

Role of second-line systemic treatment post-docetaxel in metastatic castrate resistant prostate cancer- current strategies and future directions - Abstract April 13, 2011

Role of magnetic resonance imaging before initial biopsy: Comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection - Abstract April 13, 2011

Closely monitoring low-risk prostate cancer, with biopsy, does not raise risk of death and discourages overtreatment April 13, 2011

In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil - Abstract April 12, 2011

Page 1424 of 1447